Andrew Callos sold $1.1M of Cytokinetics (CYTK)

Executed Jun 1, disclosed Jun 1, the same day.

Value, as filed

$1.1M

15,000 sh × $74.08

Executed

Jun 1

the trade date, as filed

Disclosed

Jun 1

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Andrew Callos EVP, Chief Commercial Officer profile →

Andrew Callos (EVP, Chief Commercial Officer) filed 18 Form 4 reports in the trailing twelve months (0 purchases, 18 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.5M of CYTK (52,486 sh × $65.95, as filed), executed Dec 5 2025.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 121 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew Callos in CYTK

CYTKSALE Cytokinetics, Incorporated $702K
10,000 sh × $70.24
Exec Aug 31
Filed Aug 31 · 4:57 PM ET CYTKSALE Cytokinetics, Incorporated $1.1M
14,000 sh × $79.88
Exec Jul 30
Filed Jul 30 · 4:26 PM ET CYTKSALE Cytokinetics, Incorporated $1.3M
15,000 sh × $85.80
Exec Jul 1
Filed Jul 2 · 5:19 PM ET CYTKSALE Cytokinetics, Incorporated $875K
11,333 sh × $77.25
Exec May 5
Filed May 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $1.0M
15,857 sh × $65.00
Exec May 1
Filed May 4 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $949K
15,000 sh × $63.26
Exec Apr 30
Filed Apr 30 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $492K
7,449 sh × $66.02
Exec Apr 15
Filed Apr 15 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $237K
3,639 sh × $65.00
Exec Mar 31
Filed Mar 31 · 5:30 PM ET